Allergy & Immunology

A French national study has identified eight emerging food allergens frequently causing anaphylaxis but not included in EU labelling rules.

A new milk allergy therapy protocol lowers the severity of gastrointestinal reactions during OIT, improving safety for patients.

A 10-year study shows allergen immunotherapy provides lasting symptom relief in local allergic rhinitis and reduces the risk of asthma and new sensitizations.

A newly reported fatal case of delayed anaphylaxis following beef consumption highlights the growing impact of alpha-gal syndrome.

Transepidermal water loss monitoring lowered anaphylaxis rates and reaction severity during peanut oral food challenges, offering a potential tool to improve diagnostic safety.

While further large-scale trials are needed, this precision-based treatment represents a promising advance in managing atopic dermatitis.

By integrating PAE into standard hospital practice, this initiative aims to reduce inaccurate allergy labels with the aim of lowering antibiotic resistance.

A large U.S. study finds people with seborrhoeic dermatitis are more likely to develop other barrier-related diseases, supporting the epithelial barrier theory.